Member Exclusive

Cell therapy weekly: Acting FDA Commissioner named as Ned Sharpless

This week: Fujifilm to acquire Biogen manufacturing site and new phase II trial will pit stem cells against MS

Go to the profile of RegMedNet
Mar 14, 2019
0
0

Please sign in or register for FREE

No comments yet.